Keyphrases
1-year Mortality
33%
30-day Mortality
33%
Acinetobacter
100%
Acinetobacter Baumannii (A. baumannii)
66%
Antibiotic Exposure
33%
Baumannii
33%
Bivariate Analysis
33%
Blood Culture
33%
Carbapenem-resistant Acinetobacter Baumannii
33%
Charlson Index
33%
Clinical Characteristics
33%
Clinical Data
33%
Clinical Outcomes
100%
Department of Veterans Affairs
33%
Descriptive Statistics
33%
Difficult-to-treat
33%
Epidemiological Data
33%
Epidemiology
100%
Extensively Drug-resistant
100%
Health Care Acquired
33%
Healthcare-associated
33%
High Mortality
66%
High Susceptibility
33%
Long-term Care
33%
Microbiology
33%
Minocycline
33%
Non-susceptible
33%
Novel Antibiotics
33%
Outcome Analysis
33%
Patient Characteristics
33%
Patient Outcomes
33%
Polymyxin
33%
Priority Antibiotics
33%
Respiratory Specimens
33%
Retrospective Cohort Study
33%
Tigecycline
33%
Treatment Options
33%
Urine Samples
33%
US Veterans
100%
Veterans Affairs
66%
Veterans Affairs Medical Center
100%
Medicine and Dentistry
Acinetobacter
100%
Acinetobacter Baumannii
60%
Antibiotics
20%
Bivariate Analysis
20%
Blood Culture
20%
Charlson Comorbidity Index
20%
Cohort Effect
100%
Infection
40%
Long-Term Care
20%
Minocycline
20%
Patient Characteristics
20%
Polymyxin
20%
Retrospective Cohort Study
20%
Tigecycline
20%
Urine Sampling
20%
Veterans Affairs
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter
100%
Acinetobacter Baumannii
100%
Antibiotics
33%
Cohort Study
33%
Epidemiology
33%
Infection
66%
Minocycline
33%
Polymyxin
33%
Tigecycline
33%